Search Results

1-20 of 25 results for subject:Blood

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, if he will make a statement on the Government's policy in using US-sourced, virally inactivated fresh frozen plasma for transfusion patients.

Asked by

David Amess (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

4 June 2003

Reference

115756; 406 c488-9W

House

House of Commons

Dept of Health

Answered by

Hazel Blears (Labour)

Answering body

Department of Health

Type

Oral answers to questions

Date

29 April 2003

Reference

404 c136-7

House

House of Commons

Dept of Health

Answered by

Hazel Blears (Labour)

Answering body

Department of Health

Type

Oral answers to questions

Date

29 April 2003

Reference

404 c136-7

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, If he will make a statement on needlestick injuries.

Asked by

Ben Chapman (Labour)

Answering body

Department of Health

Oral questions - Lead

Status

Answered

Date

29 April 2003

Reference

404 c136-7; 109803

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what estimate he has made of the risk of blood stocks becoming contaminated from blood donated from those who have received blood transfusions in the last 10 years; if he will publish Advisory Committee of the Microbiological Safety of Blood and Tissues...

Asked by

Dai Havard (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

28 April 2003

Reference

404 c82W; 103983;103982

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how much NHS money has been paid out in each of the last five years to people as a result of (a) clinical errors from blood transfusions and (b) infection from contaminated blood and blood product. - Inc tables.

Asked by

Dai Havard (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

17 March 2003

For answer on

28 April 2003

Answered on

28 April 2003

Mr. Havard: To ask the Secretary of State for Health how much NHS money has been paid out in each of the last five years to people as a result of (a) clinical errors from blood transfusions and (b) infection from contaminated blood and blood product. [103981] Ms Blears: Information is not collected separately on compensation for clinical errors from blood transfusions and infection from contaminated blood and blood products arising in National Health Service hospitals. However, the NHS Summarised Accounts in England specify that the gross figure for all claims for clinical negligence in 2001-02 was £446 million. The National Blood Authority (NBA) has settled seven claims in the past five years, which involve either clinical errors from blood transfusions or infection from contaminated blood or blood products. The table shows the total payments made by the NBA in respect of these claims including the legal costs of both sides. _________________________________________________________________________________________________. Year Clinical errors from blood transfusions Infection from contaminated blood and blood products 1998-99 7,131 0 1999-2000 0 0 2000-01 0 99,188 2001-02 29,320 485,739 2002-03 0 1,098,147 Total 36,451 1,683,074 _________________________________________________________________________________________________. In addition, the NBA has made payments of: _________________________________________________________________________________________________. Year £ 2001-02 5,114,035 2002-03 6,105,277 _________________________________________________________________________________________________. following Mr. Justice Burton's judgment of 26 March 2001 under the Consumer Protection Act 1987 in respect of patients infected with hepatitis C through blood transfusions between March 1988 and September 1991.

Date

28 April 2003

Reference

103981; 404 c256-7W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many people gave blood in Buckinghamshire in (a) 2001-02 and (b) 2002-03. - Includes table.

Asked by

John Bercow (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

11 April 2003

Reference

106935; 403 c441W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, which government department or agency holds (a) reports of the Blood Transfusion Service Working Group on ALT testing, (b) minutes of meetings of regional transfusion directors, (c) minutes of meetings of the governing body of the (i) National Blood Transfusion Service and...

Asked by

Mark Lazarowicz (Labour; Co-operative Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

9 April 2003

Reference

100940; 403 c316W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many people in the UK in the last five years have died from (a) hepatitis C, (b) HIV and AIDS and (c) vCJD; and how many of them were blood donors.

Asked by

Dai Havard (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

17 March 2003

For answer on

9 April 2003

Answered on

9 April 2003

Mr. Havard: To ask the Secretary of State for Health how many people in the UK in the last five years have died from (a) hepatitis C, (b) HIV and AIDS and (c) vCJD; and how many of them were blood donors. [103980] Ms Blears: Information on the number of deaths from hepatitis C, collected by the Office for National Statistics, is shown in column A of the following table. It is not known how many of these individuals were blood donors. Every unit of blood collected by the United Kingdom Blood Services (UKBS) has been tested for hepatitis C since 1991. The figures shown in column B are the number of deaths in the United Kingdom in HIV-infected individuals with or without reported AIDS. Numbers for recent years will rise as further reports are received. The Health Protection Agency, formerly the Public Health Laboratory Service, collates reports on HIV and AIDS diagnoses and deaths in HIV-infected individuals. Column C shows the number of deaths in England and Wales of HIV-infected individuals whose infection was identified as a result of donating blood. A positive HIV test will mean that the donated blood is not used. All donated blood has been tested for HIV since 1988. The chance of being infected with HIV through blood donations is currently less than one in 10 million. The National CJD Surveillance Unit collects information on the number of people who have died from vCJD. The UKBS have traced how many were blood donors. These figures are shown in columns E and F. _________________________________________________________________________________________________. A B C E F Deaths1 in England Deaths in UK of Deaths in Deaths in UK from Blood donors traced and Wales where the HIV- infected HIV-infected vCJD by UKBS who died underlying cause of individuals with individuals who from vCJD death2 was have given blood hepatitis C3 1998 92 507 5 18 2 1999 92 467 5 15 1 2000 125 475 2 28 3 2001 123 381 2 20 1 2002 4-- 310 2 17 2 _________________________________________________________________________________________________. 1 These figures are likely to underestimate the true mortality related to hepatitis C for several reasons: the certifying doctor may not always know about the existence of a hepatitis C infection, contracted many years earlier, that had given rise to another fatal liver disease. where several other factors (e.g. alcohol, other blood-borne viruses) contributed to fatal chronic liver disease, the certifying doctor may judge that one of the other factors is more important. deaths with an underlying cause of primary liver cancer are not included, even if certified as being the result of hepatitis C infection. This is because international coding rules in use at this time do not accept cancers being due to infections, except in the case of HIV/AIDS. 2 The underlying cause of death is the disease or condition that initiates the train of morbid events leading directly to death. 3 For the years 1997 to 2000, selected using a combination of underlying cause codes 070.4-070.5 from the International Classification of Diseases, Ninth Revision (ICD-9) and the presence of text referring to hepatitis C on the death certificate. For the year 2001 underlying cause codes B17.1 and B18.2 from the International Classification of Diseases, Tenth Revision (ICD-10) were used. 4 Information not yet available.

Date

9 April 2003

Reference

103980; 403 c318-20W

House

House of Commons

Westminster Hall adjournment debate on treating anaemia in cancer patients

Westminster Hall adjournment debate on treating anaemia in cancer patients.

Lead member

Dai Havard

Answering member

Hazel Blears

Department

Department of Health

Type

Adjournment debates

Date

26 March 2003

Reference

402 c123-31WH

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, pursuant to his Answer of 6th March, 400 c1209W, on haemophilia, when the strategy will be put in place to roll out access to recombinant clotting factors.

Asked by

Cheryl Gillan (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

25 March 2003

Reference

103528; 402 c198W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, pursuant to the statement of 12th February 2003 at 399 c51WS, on Haemophilia (Recombined Clotting Factors), how much will be allocated to (a) Chesham and Amersham and (b) Buckinghamshire.

Asked by

Cheryl Gillan (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

6 March 2003

Reference

100956; 400 c1209W;400 c1198W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans he has to monitor the use of the allocation of money to NHS haemophilia treatment centres in England for treating patients with genetically engineered recombinant instead of products made from human blood; when the first patients will receive the new...

Asked by

Bob Russell (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

6 March 2003

Reference

99652; 400 c1209W;400 c1198-9W

House

House of Commons

Written statement on finance to provide recombinant clotting factors for haemophilia patients in England

Written statement on finance to provide recombinant clotting factors for haemophilia patients in England.

Member

Hazel Blears (Labour)

Department

Department of Health

Type

Written statements

Date

12 February 2003

Reference

399 c51WS

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many hospitals are capable of intraoperative cell salvage of blood supplies during surgery; what has been the impact of intraoperative cell salvage on blood supplies to hospital operating theatres. - This information is not collected and inc ref to 'Better Blood...

Asked by

Tim Loughton (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

12 February 2003

Reference

399 c819W;399 c817W; 96031;96032

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make a statement on the level of blood stocks available to NHS hospitals in the United Kingdom. - Inc figure.

Asked by

Tim Loughton (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

12 February 2003

Reference

96095; 399 c809W;399 c807W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, when The Appropriate Use of Blood working group will publish its report on the use of alternative blood therapies in place of transfusing blood.

Asked by

Dai Havard (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

7 February 2003

Reference

95573; 399 c469-70W;399 c467-8W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, whether recombinant treatment products will be made available this year to all haemophilia sufferers in (a) England and (b) Northern Ireland.

Asked by

Michael Connarty (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

22 January 2003

Reference

91283; 398 c390W;398 c389W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what representations were (a) sought and (b) received from the Scottish Executive regarding the purchase of Life Resources Incorporated; and what consultations have taken place between his Department and the Scottish Executive regarding acccess to resources stored in Life Resources Incorporated; what...

Asked by

Pete Wishart (Scottish National Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

14 January 2003

Reference

397 c528-9W;397 c526-7W; 88780;88781;88782;88783;88784

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what measures he is taking to protect doctors in the UK from being prosecuted for prescribing contaminated blood.

Asked by

Dai Havard (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

19 December 2002

Reference

396 c1059W;396 c1057W; 86266

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher